Skip to main content

Surgery News (Page 12)

Having Diabetes Raises Risk of Failure With Spinal Fusion Surgery

FRIDAY, July 12, 2024 – Diabetes can make lumbar spinal fusion surgery much more likely to fail, a new study says. People with diabetes are nearly three times more likely to have their vertebrae...

Rates of Gender-Affirming Surgery Examined in Cisgender Males, Gender-Diverse

WEDNESDAY, July 10, 2024 – For adults and minors, most breast reductions performed on cisgender males and transgender and gender-diverse (TGD) people are performed on cisgender males, according to a...

Just a Few Surgeries Make Up Most Post-Op Opioid Prescriptions

WEDNESDAY, July 3, 2024 – Opioid addiction often starts with a prescription for post-surgery pain relief, and two new studies identify a handful of procedures that account for large shares of those...

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 – For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant modified 5-fluorouracil,...

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

MONDAY, July 1, 2024 – Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study...

Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures

WEDNESDAY, June 26, 2024 – Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a study published online...

FDA Medwatch Alert: SterRx, LLC Issues Voluntary Nationwide Recall of Certain SterRx Products

SterRx, LLC today announced the voluntary nationwide recall of approximately 240 lots within their expiry period due to equipment and process issues that could lead to a lack of sterility assurance...

FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals Not to Use Compounded Products Intended to be Sterile from Prescription Labs Inc. dba Greenpark Compounding Pharmacy

September 17, 2021 – FDA is alerting patients and health care professionals not to use compounded products intended to be sterile, produced and distributed nationwide by Prescription Labs Inc. doing...

FDA Approves Posimir (bupivacaine) for Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ – DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved Posimir (bupivacaine solution) for...

FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure

May 21, 2018 – The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are...

FDA Approves Vonvendi [von Willebrand factor (recombinant)] for Perioperative Management of Bleeding in Adult Patients with von Willebrand Disease

Cambridge, Ma. – April 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare disease, today announced the U.S. Food and Drug Administration (FDA) has approved Von...

Pacira Announces FDA Approval of Exparel as a Nerve Block to Produce Regional Analgesia

PARSIPPANY, N.J., April 06, 2018 (GLOBE NEWSWIRE) – Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug...

FDA Medwatch Alert: Compounded Sterile Products by PharMEDium Services: Recall - Lack of Sterility Assurance

ISSUE: PharMEDium Services is voluntarily recalling certain lots of drug products to the hospital/user level due to a lack of assurance of sterility. Administration of a drug product intended to be...

FDA Medwatch Alert: Sterile Drug Products by Cantrell Drug Company: Recall - Lack of Sterility Assurance

[Posted 07/25/2017] ISSUE: Cantrell Drug Company is voluntarily recalling all lots of unexpired sterile drug products to the hospital and user level due to lack of sterility assurance. The recalled ...

FDA Medwatch Alert: Potassium Phosphate and Succinylcholine Chloride by PharMEDium Services: Recall - Lack of Sterility Assurance

[Posted 06/27/2017] ISSUE: PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc.’s (“Hospira”) June 15, 2017 recall announcement that microbial growth was detected during ...

Ask a question

To post your own question to our community, sign in or create an account.